These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21285998)

  • 41. Proposed guidelines for screening of metabolic and endocrine diseases of dependent neonates of the U.S. Armed Forces. Derived from a survey of state guidelines for neonatal screening of metabolic diseases.
    Tiwary CM
    Clin Pediatr (Phila); 1987 Jul; 26(7):349-54. PubMed ID: 3595040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of expanded newborn screening--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China.
    Yang CJ; Wei N; Li M; Xie K; Li JQ; Huang CG; Xiao YS; Liu WH; Chen XG
    BMC Pediatr; 2018 Mar; 18(1):110. PubMed ID: 29534692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal screening: from the 'Guthrie age' to the 'genetic age'.
    Dhondt JL
    J Inherit Metab Dis; 2007 Aug; 30(4):418-22. PubMed ID: 17505914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.
    Hinton CF; Mai CT; Nabukera SK; Botto LD; Feuchtbaum L; Romitti PA; Wang Y; Piper KN; Olney RS
    Genet Med; 2014 Jun; 16(6):484-90. PubMed ID: 24310309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [25 years Austrian screening program for inborn errors of metabolism at the Vienna University].
    Widhalm K
    Wien Klin Wochenschr; 1992; 104(16):510-3. PubMed ID: 1413809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening newborns for inborn errors of metabolism by tandem mass spectrometry.
    Wilcken B; Wiley V; Hammond J; Carpenter K
    N Engl J Med; 2003 Jun; 348(23):2304-12. PubMed ID: 12788994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Newborn screening: a prime example for effective secondary prevention].
    Nennstiel-Ratzel U; Lüders A; Blankenstein O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):139-45. PubMed ID: 25475525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of newborn screening in the era of tandem mass spectrometry: what's new for the pediatric neurologist?
    Copeland S
    Semin Pediatr Neurol; 2008 Sep; 15(3):110-6. PubMed ID: 18708000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The changing face of newborn screening: diagnosis of inborn errors of metabolism by tandem mass spectrometry.
    Jones PM; Bennett MJ
    Clin Chim Acta; 2002 Oct; 324(1-2):121-8. PubMed ID: 12204433
    [No Abstract]   [Full Text] [Related]  

  • 51. [Model project for reorganising of newborn screening].
    Nennstiel-Ratzel U; Liebl B; Zapf A
    Gesundheitswesen; 2003 Mar; 65 Suppl 1():S31-5. PubMed ID: 12649792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Newborn screening for metabolic disorders: how are we doing, and where are we going?
    Bennett MJ; Rinaldo P; Wilcken B; Pass KA; Watson MS; Wanders RJ
    Clin Chem; 2012 Feb; 58(2):324-31. PubMed ID: 21865484
    [No Abstract]   [Full Text] [Related]  

  • 53. Newborn screening.
    Wilcken B; Wiley V
    Pathology; 2008 Feb; 40(2):104-15. PubMed ID: 18203033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcome of expanded newborn screening at Boston children's hospital: benefits and challenges in defining true disease.
    Landau YE; Waisbren SE; Chan LM; Levy HL
    J Inherit Metab Dis; 2017 Mar; 40(2):209-218. PubMed ID: 28054209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expanded newborn screening in Europe 2007.
    Bodamer OA; Hoffmann GF; Lindner M
    J Inherit Metab Dis; 2007 Aug; 30(4):439-44. PubMed ID: 17643197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The failure to diagnose inborn errors of metabolism in New Zealand: the case for expanded newborn screening.
    Wilson C; Kerruish NJ; Wilcken B; Wiltshire E; Webster D
    N Z Med J; 2007 Sep; 120(1262):U2727. PubMed ID: 17891215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of metabolic disease.
    Snyderman SE
    Pediatr Clin North Am; 1971 Feb; 18(1):199-208, ix. PubMed ID: 25868185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. National newborn screening program still a hype or a hope now?
    Kapoor S; Gupta N; Kabra M
    Indian Pediatr; 2013 Jul; 50(7):639-43. PubMed ID: 23942430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newborn screening: After the thrill is gone.
    Vockley J
    Mol Genet Metab; 2007; 92(1-2):6-12. PubMed ID: 17604202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.